ROSUVASTATIN SANDOZ FILM COATED TABLET 20MG
Product details
Registration number: SIN14953P
Classification: Prescription Only
Active ingredients: ROSUVASTATIN CALCIUM 20.79MG EQV ROSUVASTATIN
Strength: 20MG
Dosage form: TABLET, FILM COATED
Route: ORAL
Registrant: SANDOZ SINGAPORE PTE. LTD.
ATC code: C10AA07
HSA approval date: 18 February 2016
Manufacturer(s):
- Novartis Pharmaceutical Manufacturing LLC
- Lek S.A.
Manufacturing country/countries: SLOVENIA; POLAND
What is the HSA registration record for ROSUVASTATIN SANDOZ FILM COATED TABLET 20MG?
ROSUVASTATIN SANDOZ FILM COATED TABLET 20MG is recorded under SIN14953P. The HSA register entry showed ACTIVE status and Prescription Only classification on 16 November 2026. Registration status can change after the date of a check.
What active ingredients and strength are recorded for ROSUVASTATIN SANDOZ FILM COATED TABLET 20MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: ROSUVASTATIN CALCIUM 20.79MG EQV ROSUVASTATIN
Strength: 20MG
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ROSUVASTATIN SANDOZ FILM COATED TABLET 20MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED
Route: ORAL
Who is the recorded registrant for ROSUVASTATIN SANDOZ FILM COATED TABLET 20MG?
According to the HSA dataset updated 7 August 2026:
Registrant: SANDOZ SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for ROSUVASTATIN SANDOZ FILM COATED TABLET 20MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Novartis Pharmaceutical Manufacturing LLC
- Lek S.A.
Manufacturing country/countries: SLOVENIA; POLAND
Where can I look up ROSUVASTATIN SANDOZ FILM COATED TABLET 20MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14953P or the exact product name ROSUVASTATIN SANDOZ FILM COATED TABLET 20MG. The general register link does not preselect this product.
What are the source dates for this ROSUVASTATIN SANDOZ FILM COATED TABLET 20MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ROSUVASTATIN SANDOZ FILM COATED TABLET 20MG record had a separate HSA register check?
A direct HSA register check on 16 November 2026, using registration number SIN14953P, recorded status ACTIVE. This is a dated observation; status can change.
HSA listed Rosuvastatin Sandoz Tablet PI.pdf with approval date 5 June 2025. The document link is recorded separately.
Registration does not confirm clinic stock or individual suitability.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)